Apr 29, 2023 08:00 AM

Chongqing Pharscin Pharmaceutical Co.,Ltd.’s Net Profit Rose 7.2% in 2022

00:00

00:00/00:00

Listen to this article 1x

Chongqing Pharscin Pharmaceutical Co.,Ltd. (重庆华森制药股份有限公司) (002907.SZ) reported a net profit of 98.4 million yuan in 2022, up 7.2% year-on-year.

Meanwhile, the company posted 785.2 million yuan in revenue, down 7.2% year-on-year.

At the end of the reporting period, it had 1.9 billion yuan in total assets and 256.3 million yuan in total liabilities, with a liability-to-asset ratio of 13.7%.

Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.

Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.

Share this article

Open WeChat and scan the QR code

GALLERY

: Gallery: Innovation Takes Off at Flying Vehicle Expo

NEWSLETTERS

Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription

PODCAST

Caixin Deep Dive: How China’s Crypto Ban Makes Disposing of Seized Assets a Lot Harder

00:00

00:00/00:00

MOST POPULAR

1: Cover Story: China’s Factory Exodus Is Turning Vietnam Into the World’s Assembler

2: Meituan Enters Open-Source AI Race With LongCat Model

3: Ex-UBS Banker in Hong Kong Jailed 10 Years for Laundering $17.2 Million

4: End of U.S. Tax Exemption Hits Chinese Air Cargo Carriers Differently

5: Alipay Fined by Luxembourg Regulator for Anti-Money Laundering Breaches